Furst DE - Search Results

1

Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials.

Bruni C, Tashkin DP, Steen V, Allanore Y, Distler O, Grotts J, Matucci-Cerinic M, Furst DE; EUSTAR, SLS I & SLS II centres collaborators. Bruni C, et al. Among authors: furst de. Clin Exp Rheumatol. 2020 May-Jun;38 Suppl 125(3):161-168. Epub 2020 Aug 27. Clin Exp Rheumatol. 2020. PMID: 32865169 Free article. Clinical Trial.

2

Why everything (or nothing) seems to work in the treatment of scleroderma.

Seibold JR, Furst DE, Clements PJ. Seibold JR, et al. Among authors: furst de. J Rheumatol. 1992 May;19(5):673-6. J Rheumatol. 1992. PMID: 1613694 No abstract available.

3

Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.

Clements PJ, Peter JB, Agopian MS, Telian NS, Furst DE. Clements PJ, et al. Among authors: furst de. J Rheumatol. 1990 Jul;17(7):908-10. J Rheumatol. 1990. PMID: 2213757

4

Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study.

Greenwald GI, Tashkin DP, Gong H, Simmons M, Duann S, Furst DE, Clements P. Greenwald GI, et al. Among authors: furst de. Am J Med. 1987 Jul;83(1):83-92. doi: 10.1016/0002-9343(87)90501-8. Am J Med. 1987. PMID: 3300327 Clinical Trial.

5

The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo.

Clements P, Lachenbruch P, Furst D, Paulus H. Clements P, et al. Arthritis Rheum. 1993 Nov;36(11):1575-9. doi: 10.1002/art.1780361112. Arthritis Rheum. 1993. PMID: 8240434 Clinical Trial.

6

Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis.

Tashkin DP, Clements PJ, Wright RS, Gong H Jr, Simmons MS, Lachenbruch PA, Furst DE. Tashkin DP, et al. Among authors: furst de. Chest. 1994 Feb;105(2):489-95. doi: 10.1378/chest.105.2.489. Chest. 1994. PMID: 8306752

7

Hypothesis for the pathogenesis of systemic sclerosis.

Furst DE, Clements PJ. Furst DE, et al. J Rheumatol Suppl. 1997 May;48:53-7. J Rheumatol Suppl. 1997. PMID: 9150119 Review.

8

Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation.

Clements PJ, Furst DE. Clements PJ, et al. Among authors: furst de. J Rheumatol Suppl. 1997 May;48:85-8. J Rheumatol Suppl. 1997. PMID: 9150125 Review.

9

The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.

Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, Lachenbruch PA, Grau RG, Seibold JR. Furst DE, et al. J Rheumatol. 1998 Jan;25(1):84-8. J Rheumatol. 1998. PMID: 9458208 Clinical Trial.

10

Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis.

Seibold JR, Clements PJ, Furst DE, Mayes MD, McCloskey DA, Moreland LW, White B, Wigley FM, Rocco S, Erikson M, Hannigan JF, Sanders ME, Amento EP. Seibold JR, et al. Among authors: furst de. J Rheumatol. 1998 Feb;25(2):302-7. J Rheumatol. 1998. PMID: 9489823 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

731 results

Search Page

Filters